Latest Commercial Rollout News

FirstWave Cloud Technology has secured an approximately A$1.06 million placement to fund sales conversion and the launch of Open-AudIT 7 and an AI fault-diagnosis product. The raise follows a sharp reduction in losses, positive operating cash flow and a lower cost base, but adds about 151.3 million shares to the register.

Klevo Group has reported a sharp FY2026 turnaround, with revenue up 324%, positive operating cash flow and cash rising to A$4.32 million. The more striking claim is its KLVR stablecoin platform, which has recorded USD 59.2 million in unaudited revenue since trial commencement ahead of a planned commercial rollout.

Yojee enters FY27 with 12 signed MOSAIC customer agreements and $10.45 million in fresh funding, but the freight software company is still loss-making and yet to generate meaningful MOSAIC revenue. Management expects initial billings in the December quarter as it works to convert signed customers into live, billable usage.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.

Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.

EBR Systems plans to file a Changes Being Effected PMA supplement in the fourth quarter to make echo-induced pacing risks and their mitigations more prominent on WiSE System labelling. The FDA has aligned with the proposed path, but the filing and final labelling changes are still ahead.

CurveBeam AI has secured FDA 510(k) clearance for CT-based bone mineral density measurement, establishing the first regulatory step towards a potential new SaaS offering. The more commercially significant HiRise weight-bearing application still requires a separate clearance.

Proteomics International has begun a controlled release of two Promarker diagnostic tests through Healius in Western Australia and the Northern Territory. National commercial sales are targeted for Q2 FY27, but uptake and revenue remain difficult to estimate at this early stage.

Peppermint Innovation has shifted from building its Philippines payments platform to commercialising it, but the FY26 report shows the business remains loss-making, balance-sheet constrained and dependent on future funding. The company reported A$217,720 in revenue, a A$2.40 million net loss and negative net assets of A$578,233.

EBR Systems has secured ISO 13485 certification for its new Santa Clara manufacturing site, paving the way for a 500% increase in WiSE System production pending FDA approval expected by year-end.

Peppermint Innovation Limited posted a $2.4 million net loss for FY26 as it shifted from platform development to commercial execution in the Philippines, achieving key regulatory milestones and securing strategic investment.

Streamplay Studio Limited surged past $13 million in revenue for FY26, driven by a full year of Noodlecake Studios' contribution, while trimming its net loss by 15%.